1. Home
  2. IDYA vs TPB Comparison

IDYA vs TPB Comparison

Compare IDYA & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.39

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Turning Point Brands Inc.

TPB

Turning Point Brands Inc.

HOLD

Current Price

$126.60

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
TPB
Founded
2015
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Tobacco
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.4B
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
IDYA
TPB
Price
$32.39
$126.60
Analyst Decision
Strong Buy
Buy
Analyst Count
14
3
Target Price
$49.67
$115.00
AVG Volume (30 Days)
858.2K
318.7K
Earning Date
02-13-2026
03-05-2026
Dividend Yield
N/A
0.23%
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$214,834,000.00
$435,716,000.00
Revenue This Year
$2,688.43
$29.51
Revenue Next Year
N/A
$11.08
P/E Ratio
N/A
$657.11
Revenue Growth
5377.66
51.72
52 Week Low
$13.45
$51.48
52 Week High
$39.28
$130.69

Technical Indicators

Market Signals
Indicator
IDYA
TPB
Relative Strength Index (RSI) 41.60 64.76
Support Level $31.54 $123.98
Resistance Level $34.66 $130.69
Average True Range (ATR) 1.38 4.18
MACD -0.32 0.31
Stochastic Oscillator 16.84 74.60

Price Performance

Historical Comparison
IDYA
TPB

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About TPB Turning Point Brands Inc.

Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.

Share on Social Networks: